Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

MedDay receives €8mm Series A investment from InnoBio and Sofinnova

Executive Summary

InnoBio (managed by CDC Entreprises) and Sofinnova Capital VII have participated in an €8mm ($10.5mm) Series A round for MedDay Pharmaceuticals, a 2011 start-up that is being incubated at Paris’ l’Institut du Cerveau et de la Moelle Epiniere (the Brain and Spinal Cord Institute). Chahra Louafi from CDC and Rafaele Tordjman from Sofinnova were the representatives from each investor.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies